News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
New Zealand Biotech Proacta Names Paul Cossum President And Chief Executive
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Proacta Inc., an oncology drug discovery company, has appointed Paul Cossum as president and chief executive.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
IPO
2026 IPO stock tracker: How newly public biotechs are performing
July 22, 2026
·
1 min read
·
Gabrielle Masson
Radiopharmaceuticals
Novartis scraps mid-stage radiopharma asset as Pluvicto soars
July 22, 2026
·
2 min read
·
Tristan Manalac
Podcast
Q2 earnings underway, FDA’s CRL kerfuffle, IPOs full speed ahead in H2
July 22, 2026
·
1 min read
·
Jef Akst
Manufacturing
Samsung Biologics targets $1.8B PolyPeptide buyout to expand in obesity
July 21, 2026
·
2 min read
·
Nick Paul Taylor
